Klaus Edvardsen
Chief Tech/Sci/R&D Officer at NYKODE THERAPEUTICS
Profile
Klaus Edvardsen is currently the Chief Research & Development Officer at Nykode Therapeutics ASA. Previously, he held the position of SVP & Head-Global Medicines Development Oncology at AstraZeneca PLC.
From 2021 to 2022, he served as the Chief Development Officer at CureVac NV.
Dr. Edvardsen obtained a doctorate degree from the University of Copenhagen.
Klaus Edvardsen active positions
| Companies | Position | Start |
|---|---|---|
| NYKODE THERAPEUTICS | Chief Tech/Sci/R&D Officer | 2022-06-30 |
Former positions of Klaus Edvardsen
| Companies | Position | End |
|---|---|---|
| CUREVAC N.V. | Corporate Officer/Principal | 2022-06-29 |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Training of Klaus Edvardsen
| University of Copenhagen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| CUREVAC N.V. | Health Technology |
| NYKODE THERAPEUTICS | Health Technology |
- Stock Market
- Insiders
- Klaus Edvardsen
